These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31295222)

  • 21. Prevalence and type distribution of human papillomavirus among 1813 men in Tanzania and the relationship to HIV status.
    Olesen TB; Iftner T; Mwaiselage J; Kahesa C; Rasch V; Ngoma T; Munk C; Kjaer SK
    Sex Transm Dis; 2013 Jul; 40(7):592-8. PubMed ID: 23965778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clearance of oral high-risk human papillomavirus infection is impaired by long-term persistence of cervical human papillomavirus infection.
    Louvanto K; Rautava J; Syrjänen K; Grénman S; Syrjänen S
    Clin Microbiol Infect; 2014 Nov; 20(11):1167-72. PubMed ID: 24890849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type-specific incidence, persistence and factors associated with human papillomavirus infection among female sex workers in Benin and Mali, West Africa.
    Tounkara FK; Téguété I; Guédou FA; Talbot D; Traoré CB; Béhanzin L; Traoré S; Goma-Matsétsé E; Aza-Gnandji M; Keita B; Guenoun J; Coutlée F; Alary M
    Int J Infect Dis; 2021 May; 106():348-357. PubMed ID: 33848674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-risk human papillomavirus types in HIV-infected and HIV-uninfected young women in KwaZulu-Natal, South Africa: implications for vaccination.
    Mbatha JN; Taylor M; Kleppa E; Lillebo K; Galappaththi-Arachchige HN; Singh D; Kjetland EF; Baay MFD; Mkhize-Kwitshana ZL
    Infect Dis (Lond); 2017 Aug; 49(8):601-608. PubMed ID: 28403727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women.
    Ermel A; Tonui P; Titus M; Tong Y; Wong N; Ong'echa J; Muthoka K; Kiptoo S; Moormann A; Hogan J; Mwangi A; Cu-Uvin S; Loehrer PJ; Orang'o O; Brown D
    BMC Infect Dis; 2019 Apr; 19(1):352. PubMed ID: 31029097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda.
    Veldhuijzen NJ; Braunstein SL; Vyankandondera J; Ingabire C; Ntirushwa J; Kestelyn E; Tuijn C; Wit FW; Umutoni A; Uwineza M; Crucitti T; van de Wijgert JH
    BMC Infect Dis; 2011 Dec; 11():333. PubMed ID: 22136570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bonafide, type-specific human papillomavirus persistence among HIV-positive pregnant women: predictive value for cytological abnormalities, a longitudinal cohort study.
    Meyrelles AR; Siqueira JD; Santos PP; Hofer CB; Luiz RR; Seuánez HN; Almeida G; Soares MA; Soares EA; Machado ES
    Mem Inst Oswaldo Cruz; 2016 Feb; 111(2):120-7. PubMed ID: 26872340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China.
    Zhang HY; Fei MD; Jiang Y; Fei QY; Qian H; Xu L; Jin YN; Jiang CQ; Li HX; Tiggelaar SM; Smith JS; Sahasrabuddhe VV; Qiao YL
    Virol J; 2014 Dec; 11():202. PubMed ID: 25481842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy.
    Sammarco ML; Del Riccio I; Tamburro M; Grasso GM; Ripabelli G
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):222-6. PubMed ID: 23395560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda.
    Kumakech E; Berggren V; Wabinga H; Lillsunde-Larsson G; Helenius G; Kaliff M; Karlsson M; Kirimunda S; Musubika C; Andersson S
    PLoS One; 2016; 11(8):e0160099. PubMed ID: 27482705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
    Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
    Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquisition and persistence of human papillomavirus 16 (HPV-16) and HPV-18 among men with high-HPV viral load infections in a circumcision trial in Kisumu, Kenya.
    Senkomago V; Backes DM; Hudgens MG; Poole C; Agot K; Moses S; Snijders PJ; Meijer CJ; Hesselink AT; Schlecht NF; Bailey RC; Smith JS
    J Infect Dis; 2015 Mar; 211(5):811-20. PubMed ID: 25261492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of and Risk Factors for Anal Oncogenic Human Papillomavirus Infection Among HIV-Infected Women in France in the Combination Antiretroviral Therapy Era.
    Heard I; Poizot-Martin I; Potard V; Etienney I; Crenn-Hebert C; Moore C; Touraine P; Cubie H; Costagliola D;
    J Infect Dis; 2016 May; 213(9):1455-61. PubMed ID: 26690345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated Expression of Human Papillomavirus-16/18 E6 Oncoprotein Associates with Persistence of Viral Infection: A 3-Year Prospective Study in China.
    Yu LL; Kang LN; Zhao FH; Lei XQ; Qin Y; Wu ZN; Wang H; Chen W; Qiao YL
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1167-74. PubMed ID: 27197295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infection with human papillomavirus and HIV among young women in Kampala, Uganda.
    Banura C; Franceschi S; Doorn LJ; Arslan A; Wabwire-Mangen F; Mbidde EK; Quint W; Weiderpass E
    J Infect Dis; 2008 Feb; 197(4):555-62. PubMed ID: 18237268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type-specific prevalence of human papillomavirus by cervical cytology among women in Brasov, Romania.
    Moga MA; Irimie M; Oanta A; Pascu A; Burtea V
    Asian Pac J Cancer Prev; 2014; 15(16):6887-92. PubMed ID: 25169541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
    Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
    Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of pregnancy to human papillomavirus among human immunodeficiency virus-infected women.
    Minkoff H; Shen X; Watts DH; Leighty R; Hershow R; Palefsky J; Tuomala R; Neu N; Zorrilla CD; Paul M; Strickler H
    Obstet Gynecol; 2006 Oct; 108(4):953-60. PubMed ID: 17012459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe.
    Fukuchi E; Sawaya GF; Chirenje M; Magure T; Tuveson J; Ma Y; Shiboski S; Da Costa M; Palefsky J; Moscicki AB; Makunike-Mutasa R; Chipato T; Smith-McCune KK
    Sex Transm Dis; 2009 May; 36(5):305-11. PubMed ID: 19295468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 seroconversion promotes rapid changes in cervical human papillomavirus (HPV) prevalence and HPV-16 antibodies in female sex workers.
    Marais DJ; Carrara H; Ramjee G; Kay P; Williamson AL
    J Med Virol; 2009 Feb; 81(2):203-10. PubMed ID: 19107974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.